Safety, Efficacy and Rituximab Levels Following Chemoimmunotherapy (Rituximab plus FAB Chemotherapy) in Children and Adolescents with Mature B-Cell Non-Hodgkin Lymphoma (B-NHL): A Children's Oncology Group Report

被引：0
|
作者：
Cairo, Mitchell S. [1 ]
Lynch, James [2 ]
Harrison, Lauren [1 ]
van de Ven, Carmella [3 ]
Gross, Thomas [4 ]
Shiramizu, Bruce [5 ]
Sanger, Warren [6 ]
Perkins, Sherrie L. [7 ]
Goldman, Stanton [8 ]
机构：
[1] Columbia Univ, Med Ctr, New York, NY 43210 USA
[2] Univ Nebraska Med Ctr, Coll Publ Hlth, Childrens Oncol Grp, Omaha, NE 96822 USA
[3] Columbia Univ, Morgan Stanley Childrens Hosp New York Presbyteri, New York, NY USA
[4] Ohio State Univ, Nationwide Childrens Hosp, Columbus, OH USA
[5] Univ Hawaii, Honolulu, HI USA
[6] Univ Nebraska Med Ctr, Dept Human Genet, Omaha, NE USA
[7] ARUP Labs, Hematopathol Off, Salt Lake City, UT USA
[8] Med City Childrens, Dallas, TX USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：310 / 310
页数：1
相关论文
共 50 条
  • [31] RESULTS OF THE ADDITION OF RASBURICASE(RU) AND RITUXMAB(RM) TO THE FAB/LMB96 CHEMOTHERAPY BACKBONE IN CHILDREN plus ADOLESCENTS(C plus A) WITH MATURE B-NHL:A CHILDREN'S ONCOLOGY GROUP REPORT
    Cairo, Mitchell S.
    Lynch, James
    Harrison, Lauren
    Perkins, Sherrie
    Sanger, Warren
    Gross, Thomas
    Shiramizu, Bruce
    Goldman, Stanton
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 858 - 858
  • [32] RITUXIMAB IN THERAPY OF PERIPHERAL B-CELL NON-HODGKIN'S LYMPHOMAS IN CHILDREN
    Valiev, T. T.
    Morozova, O. V.
    Makhonova, L. A.
    Mentkevich, G. L.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2010, 55 (03): : 13 - 16
  • [33] Clinical experience with biweekly CHOP plus rituximab chemoimmunotherapy for the treatment of aggressive B-cell non-Hodgkin lymphoma
    David Aguiar Bujanda
    José Aguiar Morales
    Uriel Bohn Sarmiento
    Salvador Saura Grau
    Carlos Rodríguez Franco
    Clinical and Translational Oncology, 2009, 11 : 604 - 608
  • [34] Clinical experience with biweekly CHOP plus rituximab chemoimmunotherapy for the treatment of aggressive B-cell non-Hodgkin lymphoma
    Aguiar Bujanda, David
    Aguiar Morales, Jose
    Bohn Sarmiento, Uriel
    Saura Grau, Salvador
    Rodriguez Franco, Carlos
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (09): : 604 - 608
  • [35] Final Report of Reduced Anthracycline Dose Intensity with the Addition of Dose Dense Rituximab in Children, Adolescents and Young Adults with De Novo Good Risk Mature B-Cell Non Hodgkin Lymphoma (B-NHL)
    Hochberg, Jessica C.
    Goldman, Stanton
    Barth, Matthew J.
    Shi, Qiuhu
    Klejmont, Liana
    Harrison, Lauren
    Basso, Jackie
    Chu, Yaya
    Islam, Humayun
    Gerard, Perry
    Oesterheld, Javier
    Heym, Kenneth Matthew
    Kirov, Ivan I.
    Drachtman, Richard A.
    Harker-Murray, Paul
    Perkins, Sherrie L.
    Miles, Rodney R.
    Shiramizu, Bruce
    Cairo, Mitchell S.
    BLOOD, 2020, 136
  • [36] Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukemia: A Children's Oncology Group (COG) report.
    Barth, Matthew John
    Goldman, Stanton
    Smith, Lynette
    Perkins, Sherrie L.
    Shiramizu, Bruce
    Gross, Thomas G.
    Harrison, Lauren
    Sanger, Warren
    Geyer, Mark B.
    Giulino, Lisa B.
    Cairo, Mitchell S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] Pharmacokinetics of rituximab associated with CHOP chemotherapy in B-cell non-Hodgkin lymphoma
    Blasco, Helene
    Chatelut, Etienne
    de Bretagne, Isabelle Benz
    Congy-Jolivet, Nicolas
    Le Guellec, Chantal
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 (05) : 601 - 608
  • [38] IMPACT OF RITUXIMAB ON IMMUNE STATUS FOLLOWING THERAPY IN CHILDREN AND ADOLESCENTS WITH HIGH-RISK MATURE B-CELL NON-HODGKIN LYMPHOMA: RESULTS OF THE INTER-B-NHL RITUX 2010 TRIAL
    Alexander, S.
    Auperin, A.
    Bomken, S.
    Csoka, M.
    Kazanowska, B.
    Chiang, A.
    Andres Moreno, M.
    Uyttebroeck, A.
    Burke, A.
    Zsiros, J.
    Pillon, M.
    Bollard, C.
    Barkauskas, D.
    Wheatley, K.
    Patte, C.
    Gross, T.
    Minard-Colin, V.
    LEUKEMIA RESEARCH, 2022, 121 : S8 - S9
  • [39] Evaluation of Epcoritamab and Rituximab Combination in Preclinical Models of B-Cell Non-Hodgkin's Lymphoma (NHL)
    Epling-Burnette, P. K.
    Dandamudi, Durga B.
    Konieczna, Iwona M.
    Calabrese, Kelly M.
    Wielgos-Bonvallet, Monica
    Kweekel, Christiaan
    Gresnigt-van den Heuvel, Elke
    Parikh, Apurvasena
    Li, Tommy
    Chiu, Christopher W.
    Chervin, Adam
    Reilly, Edward B.
    Szafer-Glusman, Edith
    BLOOD, 2022, 140 : 9283 - 9285
  • [40] Relationship between exposure and safety/efficacy of loncastuximab tesirine (Lonca) in B-cell non-Hodgkin lymphoma (B-NHL).
    Hess, Brian
    Ai, Weiyun
    Townsend, William
    Ungar, David
    Liao, Sam
    Liao, Lori
    Zhang, Xiaoyan
    Boni, Joseph
    CANCER RESEARCH, 2021, 81 (13)
12345